Business Wire

BreezoMeter Closes Series B Fundraising with $7.75M USD

Del

BreezoMeter, a global provider of hyperlocal air quality data and pollen information, announces the completion of a series B funding, totaling $7.75 Million USD, led by Goldacre and Entrée Capital . In 2014 BreezoMeter was the first company to introduce location-based and real-time air quality data, available via API, to businesses. Since then the company has landed major partnerships in the smart home, medical, automotive and lifestyle industries and has received investments totaling $12.5M USD.

BreezoMeter was founded in 2014 by three graduates of Israel’s Technion Institute of Technology: environmental engineers Ran Korber (CEO) and Ziv Lautman (CMO), and software engineer Emil Fisher (CTO). The founders were looking to buy family homes in the healthiest, cleanest areas in Israel, but realized they didn’t have access to relevant, location-based data that could help them. This drove them to create a company that could provide that insight.

Air quality awareness is increasing, as cities around the world struggle to control rising pollution levels. 80% of people living in urban areas are exposed to air pollution levels considered unhealthy by the World Health Organization. Air pollution kills 7 million people, linked to 1 in 8 deaths a year, and it is therefore critical for companies to reach out to their customers with relevant, real-time, location-based data that can help them reduce their exposure to harmful pollutants. Progress is being made as air quality data is also becoming increasingly democratized, as experienced by more news headlines and user-oriented search results.

Investing in The Future of Air Quality

Goldacre, an innovative family office investment house that forms part of the Noé Group’s £2bn asset management business, co-led the investment with Entrée Capital, a leading international venture capital firm. Also participating were Idinvest Partners, a European leader in financing small and medium-sized enterprises with almost €8 billion under management; and HELLA Ventures, the venture capital arm of HELLA, one of the leading automotive suppliers for lighting technology and electronics with more than 40,000 employees in some 35 countries. Also joining the funding round were AxessVentures, and Plug ‘n’ Play Ventures from Silicon Valley.

Idinvest Partners’ and HELLA Ventures’ investments are part of BreezoMeter’s strategy to expand in the mobility market. The funding round will enable BreezoMeter to further develop its smart cities solutions, already being used by companies like Cisco, Faurecia and others, and to expand its offering by utilizing proprietary spatial interpolation algorithms to integrate low-cost sensors data. This addition of small sensor data, to the already robust 1.8 TB of data that is processed hourly, will enable a higher resolution of air quality data in urban areas, down to just 30 meters.

Idinvest Partners’ expansive network will support BreezoMeter’s expansion in the European and Asian markets, while AirShield, HELLA Ventures’ automotive solution for in-cabin air pollution monitoring, will integrate with BreezoMeter’s outdoor air quality data, and will address the health risks drivers and passengers face as a consequence of pollution.

"Companies and Cities see the need to address the complex challenge that air pollution creates for their customers and citizens, and Breezometer has built an innovative solution for them to integrate and provide accurate air quality data, everywhere, and in real time. We are delighted to support BreezoMeter's rapid expansion,” said Matthieu Bonamy, Senior Investment Director at Idinvest Partners.

"Our next generation environmental solutions will help smart cities reduce pollution levels, and protect their citizens with smart traffic management solutions, focusing on strategic areas with sensitive populations. For the automotive industry, we are introducing the most comprehensive solutions to protect drivers and passengers from air pollution, as they are often exposed to levels even higher than the surrounding outdoor air." Ran Korber, co-founder and CEO of BreezoMeter.

Emil Fisher, co-founder and CTO added, “The future of air quality is complex, and the most powerful tool we have to improve the lives of billions of people around the world is through data and education. Previous funding rounds helped us establish our presence in North America and Europe, as well as partner with some of the world's largest companies. This funding round will enable us to expand our market offering to new and exciting markets all around Asia.”

“The Goldacre team looks for exceptional and passionate founders that drive innovation through technology in the built environment. For us, BreezoMeter represents a unique opportunity to invest in the future of smart cities and the innovation that intersects between the physical and digital worlds. We’re always looking for genuine innovation that aims to solve current environmental problems and ultimately enhance the spaces in which we live and work and we believe we are only at the beginning of a wave of tech innovation to tackle environmental problems, of which air pollution and climate change are some of the most significant,” says David Bloom, Partner at Goldacre

Goldacre is an innovative family office investment house, which specialises in supporting early-stage technology-led businesses working with the built environment to scale up through strategic investment, advice and management. As part of the Noé Group, it leverages the scale of a £2bn asset management business with the nimbleness of a boutique. Goldacre’s portfolio spans the UK, Europe and Israel.

Entrée Capital, with offices in Israel, UK, and the US, was founded in 2009 to provide multi-stage funding to innovative seed, early and growth stage companies all over the world. Entrée Capital manages over $300m across a number of funds and its portfolio includes Snapchat, monday.com, and over 50 other investments

Idinvest Partners is a leading pan-European private equity firm focused on the mid-market segment with €8 billion under management, and has developed several complementary areas of expertise including growth capital investments in innovative European start-ups and secondary investments in unlisted European companies and private equity consulting. Founded under the name AGF Private Equity in 1997, Idinvest Partners was formerly part of Allianz until 2010 when it became an independent firm

BreezoMeter, the world leader in location-based, real-time air quality data, addresses air pollution in a way that can help billions of people worldwide improve their health. Combining data from governmental sensors, satellites, weather, transportation and other sources, the BreezoMeter APIs give businesses the tools to increase user engagement and sales, and positively impact lives with accurate, relevant, and intuitive data, which easily integrates into products relating to smart homes, fitness and lifestyle, cosmetics, automotive, and health technologies.

Contact information

BreezoMeter
Media
Idit Lowenstein, +972-54-943-1533
Director of Marketing
marketing@breezometer.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pioneering Project for Pharmaceutics – Vifor Pharma and the University of Basel are Jointly Establishing the World’s First Research Professorship for Nanopharmaceutical and Regulatory Science26.5.2019 07:00:00 CESTPressemelding

Nanopharmaceutics promises ground-breaking innovation in the development of medicines: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190526005014/en/ The Vifor Pharma Group is endowing two professorships for Nanopharmaceutical and Regulatory Science at the University of Basel The commitment by Vifor Pharma and the University of Basel is aimed at ensuring Switzerland has the specialist knowledge and equipment needed to compete globally in this important emerging area of life sciences With this decision, Vifor Pharma is demonstrating its commitment to Switzerland as a world-leading location for pharmaceutical research and development Nanomedicines are playing an increasingly important role in the development of innovative new medications. These drugs are able to overcome specific cellular barriers in the human body with a view to targeting their effect even more precisely. Nanopharmacy therefore promises to help advance medic

XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 18:20:00 CESTPressemelding

On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 14:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 10:20:00 CESTPressemelding

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CESTPressemelding

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta